| miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome (NCT02418195) | University of Alabama at Birmingham | 2015-04-20 |
| Role of Pentoxifylline as an Adjuvant Therapy for Adult Patients With Major Depressive Disorder (NCT03554447) | Mahmoud Samy Abdallah | 2015-04-20 |
| Vagus Nerve Stimulation: Integration of Behavior and Cardiac Modulation (NCT04467164) | Massachusetts General Hospital | 2015-04-15 |
| The Effect of tDCS in Patients With Moderate to Severe Major Depressive Disorder (NCT02657980) | Ybrain Inc. | 2015-04-01 |
| 5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females (NCT02356107) | Perry Renshaw | 2015-04-01 |
| Connectivity Affecting the Antidepressant REsponse Study (NCT02332291) | Vanderbilt University Medical Center | 2015-04-01 |
| Efficacy of Cognitive Behavioral to Hypnotherapeutic Treatment of Depression (NCT02375308) | University Hospital Tuebingen | 2015-04-01 |
| Mood Patient Powered Research Network (MoodNetwork) (NCT02453438) | Massachusetts General Hospital | 2015-03-01 |
| IntelliCare: Artificial Intelligence in a Mobile Intervention for Depression and Anxiety (AIM) (NCT02176226) | Northwestern University | 2015-03-01 |
| A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise (NCT02407704) | Kirk Erickson, PhD | 2015-03-01 |
| Task Sharing for the Care of Severe Mental Disorders in a Low-income Country (NCT02308956) | University of Cape Town | 2015-03-01 |
| Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD) (NCT02371980) | Takeda | 2015-02-10 |
| Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder (NCT02362529) | Centre for Addiction and Mental Health | 2015-02-01 |
| Study of Safety, Tolerability and Pharmacokinetics of NRX-1074 in Normal Healthy Volunteers (NCT02366364) | Naurex, Inc, an affiliate of Allergan plc | 2015-02-01 |
| Clinical Registry of Patients Under Treatment With Atypical Antipsychotics (NCT02409823) | Pontifical Catholic University of Argentina | 2015-02-01 |
| Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine (NCT02332954) | Lundbeck Canada Inc. | 2015-02-01 |
| Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients (NCT02188121) | Mclean Hospital | 2015-02-01 |
| Pharmacogenetic Testing on an Outpatient Population With a Depression Diagnosis (NCT02443584) | Avera McKennan Hospital & University Health Center | 2015-02-01 |
| e-Compared-S: Comparative Effectiveness Research on Internet-based Depression Treatment - Spanish Trial (NCT02361684) | Universitat Jaume I | 2015-02-01 |
| Adjunct Minocyline in Treatment-resistant Depression (NCT02456948) | Charite University, Berlin, Germany | 2015-01-01 |
| A Multimodal Neuroimaging Study of Brain Activation Patterns Under Ketamine (NCT03609190) | Psychiatric University Hospital, Zurich | 2015-01-01 |
| Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder (NCT02461927) | VA Office of Research and Development | 2015-01-01 |
| Partnership in Medication Management (PIMM) in Patients With Mood Disorders (NCT02285608) | St. Joseph's Healthcare Hamilton | 2015-01-01 |
| Family Psychoeducation for Major Depressive Disorder (NCT02348827) | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital | 2015-01-01 |
| An Open Label Study of the Genecept™ Assay in Treatment Resistant Depression (NCT01438242) | Genomind, LLC | 2015-01-01 |
| Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial (NCT03121573) | Taichung Veterans General Hospital | 2014-12-15 |
| Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis (NCT02330679) | University of Calgary | 2014-12-01 |
| Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder (NCT02294305) | The Medical Research Network | 2014-12-01 |
| Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine (NCT02263248) | Centre for Addiction and Mental Health | 2014-12-01 |
| Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder (NCT02272517) | H. Lundbeck A/S | 2014-12-01 |
| Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder (NCT02134808) | Perry Renshaw | 2014-11-21 |
| Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders (NCT01947647) | VA Office of Research and Development | 2014-11-17 |
| Acupuncture in Depression: From the Clinical Trial, Biomarkers to Molecular Biology (NCT03452384) | National Science and Technology Council, Taiwan | 2014-11-06 |
| Mental Health Telemetry for Self-Management in Major Depression (NCT01999010) | Sunnybrook Health Sciences Centre | 2014-11-01 |
| Biomarkers of Social Sensitivity in Major Depression (NCT02214511) | Institut National de la Santé Et de la Recherche Médicale, France | 2014-10-23 |
| Multicomponent Yoga Intervention for Major Depressive Disorder (NCT02616549) | University of Pennsylvania | 2014-10-01 |
| A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A) (NCT02269540) | Centre for Addiction and Mental Health | 2014-10-01 |
| Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive Disorder (NCT02279953) | H. Lundbeck A/S | 2014-10-01 |
| rTMS for PTSD Comorbid With Major Depressive Disorder (NCT02273063) | Butler Hospital | 2014-10-01 |
| Improving Therapeutic Learning in Depression: Proof of Concept (NCT02376257) | Boston University Charles River Campus | 2014-09-16 |
| Open Label Extension for GLYX13-C-202, NCT01684163 (NCT02192099) | Naurex, Inc, an affiliate of Allergan plc | 2014-09-08 |
| Neurobiological Effects of Light on MDD (NCT02940769) | University of Michigan | 2014-09-04 |
| Clinical Effect of dTMS in Major Depressive Disorder (NCT03265340) | Section for Affective Disorders; Northern Stockholm Psychiatry | 2014-09-01 |
| Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans (NCT01851967) | Massachusetts General Hospital | 2014-09-01 |
| Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy (NCT02238730) | Kaiser Permanente | 2014-09-01 |
| Cognitive Training for Mood and Anxiety Disorders (NCT02256566) | Icahn School of Medicine at Mount Sinai | 2014-09-01 |
| Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations (NCT04296604) | Massachusetts General Hospital | 2014-09-01 |
| Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine (NCT02176291) | Jordan F. Karp | 2014-08-01 |
| Glutamate Probes in Adolescent Depression (NCT02307617) | Mayo Clinic | 2014-08-01 |
| Transdiagnostic iCBT for Depression and Anxiety (NCT02266693) | Centre for Addiction and Mental Health | 2014-08-01 |
| Study to Treat Major Depressive Disorder (MDD) With a New Medication (NCT02149836) | Icahn School of Medicine at Mount Sinai | 2014-08-01 |
| The Neurobiology of Approach Avoidance Training in Depression (NCT02330744) | University of California, San Diego | 2014-07-01 |
| Enhancing Psychotherapy for Mood Disorders With Whole Body Hyperthermia (NCT02021149) | Charles (Chuck) Raison | 2014-07-01 |
| A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study (NCT02218008) | Alkermes, Inc. | 2014-07-01 |
| Clinical Study of Generic and Brand Bupropion in Depression (NCT02209597) | Washington University School of Medicine | 2014-06-25 |
| Deep Brain Stimulation in Patients With Chronic Treatment Resistant Depression (NCT01973478) | Rennes University Hospital | 2014-06-03 |
| Biomarkers of Fast Acting Therapies in Major Depression (NCT02165449) | University of California, Los Angeles | 2014-06-01 |
| Chronotherapy Randomized Controlled Trial (NCT02176824) | Medical University of South Carolina | 2014-06-01 |
| Efficacy of Adjunctive Exercise for the Behavioral Treatment of Major Depression (NCT02176408) | Boston University Charles River Campus | 2014-06-01 |
| Noradrenergic Activity, Cognition and Major Depressive Disorder (NCT02470026) | Charite University, Berlin, Germany | 2014-06-01 |
| Neuroimaging MAO-B in Medication Free TR-MDD Using Novel Tracer (NCT02153281) | Centre for Addiction and Mental Health | 2014-06-01 |
| A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for Suicide (NCT02133001) | Janssen Research & Development, LLC | 2014-05-23 |
| A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study (NCT02158546) | Alkermes, Inc. | 2014-05-01 |
| A Long-Term Safety Study of ALKS 5461 (NCT02141399) | Alkermes, Inc. | 2014-05-01 |
| A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study (NCT02158533) | Alkermes, Inc. | 2014-05-01 |
| Comparison of Anodal Transcranial Direct Current Stimulation (t-DCS) and Sham Stimulation in Patients With Treatment-resistant Depression (NCT02141776) | University of Florida | 2014-05-01 |
| Automatic Self Transcending Meditation Versus Treatment as Usual (NCT02149810) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2014-05-01 |
| Pilot Study Assessing Computerized Cognitive Behavioral Therapy for Depression (NCT01990053) | Ohio State University | 2014-04-14 |
| Effect of Amygdala Neurofeedback on Depressive Symptoms and Processing Biases (NCT02079610) | Laureate Institute for Brain Research, Inc. | 2014-04-01 |
| Comparison of the Efficacy, Safety, and Relapse of ECT to ECT Plus Agomelatine for Depressed Patients (NCT04181567) | Kaohsiung Kai-Suan Psychiatric Hospital | 2014-03-03 |
| Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder (NCT02067793) | Naurex, Inc, an affiliate of Allergan plc | 2014-03-01 |
| Pharmacogenetic Decision Support IT System for Psychiatric Hospitalization: RCT (NCT02120729) | Hartford Hospital | 2014-03-01 |
| Mobile Apps for the Treatment of Depression (NCT02024620) | Central Arkansas Veterans Healthcare System | 2014-03-01 |
| Functional and Metabolic Changes in the Course of Antidepressive Treatment (NCT02099630) | Charite University, Berlin, Germany | 2014-03-01 |
| Pilot Study Comparing 10hz vs Theta Burst Stimulation (NCT02800226) | University of British Columbia | 2014-03-01 |
| Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults (NCT01973283) | New York State Psychiatric Institute | 2014-02-19 |
| Mechanisms of Antidepressant Non-Response in Late-Life Depression (NCT01931202) | New York State Psychiatric Institute | 2014-02-19 |
| Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN) (NCT02051413) | Institut National de la Santé Et de la Recherche Médicale, France | 2014-02-18 |
| Assess the Efficacy and Safety of ASC-01 in Patients With Major Depressive Disorder (NCT02046564) | Otsuka Pharmaceutical Co., Ltd. | 2014-02-01 |
| A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD) (NCT02085135) | Alkermes, Inc. | 2014-02-01 |
| Can Magnetic Brain Stimulation Help Prevent Relapse in Depression? (NCT02029963) | University of Manitoba | 2014-02-01 |
| Safety, Tolerability and Pharmacokinetics Study of LY03005 (NCT02055300) | Luye Pharma Group Ltd. | 2014-02-01 |
| Imaging Dopamine Release in Depression (NCT02033369) | New York State Psychiatric Institute | 2014-02-01 |
| A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive Disorder (NCT01957410) | Janssen Research & Development, LLC | 2014-02-01 |
| Impact of an Eight Week Exercise Intervention in Treating Major Depressive Disorder (NCT03191994) | University of Ontario Institute of Technology | 2014-01-02 |
| Integral Assessment in Unipolar Depression (NCT02268487) | University of Sao Paulo | 2014-01-01 |
| The Effect of Ketamine on Mechanises Underlying Suicidal Ideation and Drug-resistant Major Depression (NCT02037503) | Tel-Aviv Sourasky Medical Center | 2014-01-01 |
| Integrated Chronotherapy for Perinatal Depression (NCT02053649) | Rhode Island Hospital | 2014-01-01 |
| Deep Brain Stimulation (DBS) Therapy for Treatment Resistant Depression (NCT02046330) | The University of Texas Health Science Center, Houston | 2013-12-16 |
| Games to Overcome Late Life Depression (NCT02229188) | University of Washington | 2013-12-01 |
| PET Imaging of Brain mGluR1 Receptors Using [18F]FIMX (NCT02230592) | National Institute of Mental Health (NIMH) | 2013-11-08 |
| Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms (NCT02013531) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2013-11-01 |
| Evaluation of a Mental Health Physician Support Program in Nova Scotia (NCT01975948) | Nova Scotia Health Authority | 2013-11-01 |
| A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment (NCT01941043) | Avalo Therapeutics, Inc. | 2013-11-01 |
| Trial of a Positive Psychology Intervention in Major Depressive Disorder (NCT02004145) | Massachusetts General Hospital | 2013-10-01 |
| Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD) (NCT02014363) | e-Therapeutics PLC | 2013-10-01 |
| Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial (NCT01894815) | University of Sao Paulo | 2013-10-01 |
| A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder (NCT01977378) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2013-10-01 |
| Brain Mechanisms of Human Motivation (NCT01976975) | Mclean Hospital | 2013-10-01 |
| Using Mental Health Telemetry to Predict Relapse and Re-hospitalization in Mood Disorders (NCT01882608) | Dr. David Kreindler | 2013-10-01 |